Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Gilstrap Obstetrics and Gynecology Fellow, CDC Foundation, Atlanta, Georgia, USA.
Clin Infect Dis. 2024 Jan 31;78(Suppl 1):S47-S54. doi: 10.1093/cid/ciad686.
Tularemia is caused by the gram-negative bacterium Francisella tularensis. Although rare, tularemia during pregnancy has been associated with pregnancy complications; data on efficacy of recommended antimicrobials for treatment are limited. We performed a systematic literature review to characterize clinical manifestations of tularemia during pregnancy and examine maternal, fetal, and neonatal outcomes with and without antimicrobial treatment.
We searched 9 databases, including Medline, Embase, Global Health, and PubMed Central, using terms related to tularemia and pregnancy. Articles reporting cases of tularemia with ≥1 maternal or fetal outcome were included.
Of 5891 articles identified, 30 articles describing 52 cases of tularemia in pregnant patients met inclusion criteria. Cases were reported from 9 countries, and oropharyngeal and ulceroglandular tularemia were the most common presenting forms. A plurality (46%) of infections occurred in the second trimester. Six complications were observed: lymph node aspiration, lymph node excision, maternal bleeding, spontaneous abortion, intrauterine fetal demise, and preterm birth. No deaths among mothers were reported. Of 28 patients who received antimicrobial treatment, 1 pregnancy loss and 1 fetal death were reported. Among 24 untreated patients, 1 pregnancy loss and 3 fetal deaths were reported, including one where F. tularensis was detected in placental and fetal tissues.
Pregnancy loss and other complications have been reported among cases of tularemia during pregnancy. However, risk of adverse outcomes may be lower when antimicrobials known to be effective are used. Without treatment, transplacental transmission appears possible. These data underscore the importance of prompt recognition and treatment of tularemia during pregnancy.
土拉热菌病是由革兰氏阴性细菌弗朗西斯菌引起的。尽管罕见,但妊娠期间的土拉热菌病与妊娠并发症有关;关于推荐的抗菌药物治疗效果的数据有限。我们进行了系统的文献回顾,以描述妊娠期间土拉热菌病的临床表现,并检查有无抗菌治疗的孕妇、胎儿和新生儿结局。
我们使用与土拉热菌病和妊娠相关的术语,在 9 个数据库(包括 Medline、Embase、全球健康和 PubMed Central)中进行了搜索。纳入报告了≥1 例孕妇或胎儿结局的土拉热菌病病例的文章。
在 5891 篇文章中,有 30 篇描述了 52 例妊娠患者的土拉热菌病病例符合纳入标准。病例报告来自 9 个国家,口咽型和溃疡腺型土拉热菌病是最常见的表现形式。多数(46%)感染发生在妊娠中期。观察到 6 种并发症:淋巴结抽吸、淋巴结切除、母亲出血、自然流产、宫内胎儿死亡和早产。未报告母亲死亡。在接受抗菌治疗的 28 例患者中,报告了 1 例妊娠丢失和 1 例胎儿死亡。在未接受治疗的 24 例患者中,报告了 1 例妊娠丢失和 3 例胎儿死亡,其中 1 例胎盘和胎儿组织中检测到土拉热菌。
在妊娠期间的土拉热菌病病例中,已报告妊娠丢失和其他并发症。然而,当使用已知有效的抗菌药物时,不良结局的风险可能较低。未经治疗,可能发生胎盘传播。这些数据强调了在妊娠期间及时识别和治疗土拉热菌病的重要性。